Ma, Y.; Nenkov, M.; Berndt, A.; Abubrig, M.; Schmidt, M.; Sandhaus, T.; Huber, O.; Clement, J.H.; Lang, S.M.; Chen, Y.;
et al. The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer. Cancers 2024, 16, 1170.
https://doi.org/10.3390/cancers16061170
AMA Style
Ma Y, Nenkov M, Berndt A, Abubrig M, Schmidt M, Sandhaus T, Huber O, Clement JH, Lang SM, Chen Y,
et al. The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer. Cancers. 2024; 16(6):1170.
https://doi.org/10.3390/cancers16061170
Chicago/Turabian Style
Ma, Yunxia, Miljana Nenkov, Alexander Berndt, Mohamed Abubrig, Martin Schmidt, Tim Sandhaus, Otmar Huber, Joachim H. Clement, Susanne M. Lang, Yuan Chen,
and et al. 2024. "The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer" Cancers 16, no. 6: 1170.
https://doi.org/10.3390/cancers16061170
APA Style
Ma, Y., Nenkov, M., Berndt, A., Abubrig, M., Schmidt, M., Sandhaus, T., Huber, O., Clement, J. H., Lang, S. M., Chen, Y., & Gaßler, N.
(2024). The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer. Cancers, 16(6), 1170.
https://doi.org/10.3390/cancers16061170